SHIONOGI & CO., LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6,643 JPY | -0.70% |
|
+6.66% | -2.28% |
| Jun. 25 | Japanese Shares Close Higher as Officials Address Yen Volatility Concerns | MT |
| Jun. 25 | Shionogi & Co Introduces Covgoze Vaccine for Covid-19 in Japan | MT |
| Sales 2025 * | 430B 2.72B | Sales 2026 * | 449B 2.84B | Capitalization | 1,883B 11.92B |
|---|---|---|---|---|---|
| Net income 2025 * | 155B 983M | Net income 2026 * | 159B 1.01B | EV / Sales 2025 * | 3.15 x |
| Net cash position 2025 * | 531B 3.36B | Net cash position 2026 * | 607B 3.84B | EV / Sales 2026 * | 2.84 x |
| P/E ratio 2025 * |
12.1
x | P/E ratio 2026 * |
11.7
x | Employees | 4,959 |
| Yield 2025 * |
2.55% | Yield 2026 * |
2.59% | Free-Float | 85.99% |
More Fundamentals
* Assessed data
More news
More recommendations
More press releases
More news
| 1 day | -0.70% | ||
| 1 week | +6.66% | ||
| Current month | +5.83% | ||
| 1 month | +9.01% | ||
| 3 months | -9.45% | ||
| 6 months | -9.11% | ||
| Current year | -2.28% |
1 week
6 215.00
6 729.00
1 month
5 980.006 729.00
Current year
5 980.008 137.00
1 year
5 785.008 137.00
3 years
5 640.008 439.00
5 years
4 379.008 439.00
10 years
2 168.008 439.00
| Managers | Title | Age | Since |
|---|---|---|---|
Isao Teshirogi
CEO | Chief Executive Officer | 64 | 82-03-31 |
Yuji Hosogai
DFI | Director of Finance/CFO | - | - |
Yasuetsu Imune
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Hiroshi Ozaki
BRD | Director/Board Member | 74 | 19-05-31 |
Isao Teshirogi
CEO | Chief Executive Officer | 64 | 82-03-31 |
Takuko Sawada
BRD | Director/Board Member | 69 | 77-03-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 4.69% | 14 M€ | +18.40% | ||
| 2.51% | 7 M€ | +8.64% | - | |
| 1.07% | 57 M€ | +27.08% | ||
| 1.05% | 10 M€ | +23.62% | - | |
| 1.04% | 240 M€ | +27.67% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-07-12 | 6,643 | -0.70% | 1,753,900 |
| 24-07-11 | 6,690 | +3.53% | 1,957,800 |
| 24-07-10 | 6,462 | +1.35% | 1,426,900 |
| 24-07-09 | 6,376 | +1.25% | 1,558,700 |
| 24-07-08 | 6,297 | +1.11% | 1,192,700 |
Delayed Quote Japan Exchange, July 12, 2024 at 02:00 am EDT
More quotes
Shionogi & Co., Ltd. specializes in development, manufacturing and marketing of pharmaceutical products. The group's activity is organized around 3 families of products:
- prescription products: drugs for the treatment of cardiovascular and infectious diseases, diabetes, allergic reactions, etc.;
- OTC products: analgesic products, vitamins and tonics, etc.;
- diagnosis products: primarily for detection and treatment of cardiovascular diseases and immune system.
Sector
Pharmaceuticals
Calendar
2024-07-29
- Q1 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
6,643
JPY
Average target price
7,590
JPY
Spread / Average Target
+14.26%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -2.28% | 11.93B | |
| +62.66% | 854B | |
| +40.42% | 636B | |
| -4.37% | 361B | |
| +17.16% | 324B | |
| +9.87% | 301B | |
| +15.66% | 247B | |
| +4.21% | 230B | |
| +17.90% | 228B | |
| +14.86% | 177B |
- Stock Market
- Equities
- 4507 Stock
